Screener

Eligibility screening

Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma

Sponsored by Abramson Cancer Center at Penn MedicineStudy detailsClinicalTrials.gov

1 US site in PA

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.